A Unique Opportunity to Own a Piece of Medicinal Organic Cannabis Australia (MOCA)

Summary of Key Points

Medicinal Organic Cannabis Australia (MOCA) is the first established organic cannabis company in Australia, with a focus on ethically sourced organic products. 

  • Licenced: Australian import, export and wholesale licences for Medical Cannabis. European approvals and subsidies to cultivate in Europe

  • Products Approved: 21 products approved in Australia by the TGA

  • Import Permits: Australian import permits from the Office of Drug Control for all its products.

  • Products: has an approved range of MOCA branded organic cannabis products & has developed a new product that could reduce patient costs by 30%

  • Distribution: has supply agreements with pharmacies and practitioners in Australia.

  • Team: is science based with 4 PhD’s on the team to ensure product quality and standard.  MOCA is  focused on leveraging digital marketing channels. Has global third party warehousing and logistics suppliers in Australia.

  • International opportunities: were finalists in 2 international tenders to supply cannabis (Italy & Barbados)

  • Facilities: has a 15 year lease on a 18,000m2 cultivation facility in Italy with subsidised water and energy costs.

Medicinal Organic Cannabis Australia (MOCA) Pty Ltd was founded in March 2017 and incorporated in June 2017. Australian State and Federal medical cannabis import, export and wholesale licences were awarded to MOCA in 2018. 

We offer a range of opportunities to take advantage of these growing markets. According to Barclays September 2018 European Consumer Staples Report the global cannabis industry could be worth USD$272 billion by 2028. European subsidised health care systems with a current budget of $1.3 trillion in spending will bring the medical cannabis market to dominate Europe and become the largest medical marijuana market in the world. 

A Unique opportunity to invest in 

Now accepting Investors - Invest in invest from as little as $250.00
The Company is offering shares direct without any broker fees. Buy shares in the leading online organic marijuana company. The Company is offering shares its to expand cultivation activities in Europe as becomes the largest organic cultivator of cannabis in Europe.

Invest in Cannabis

A 2018 cannabis report from Deloitte found 74 percent of people surveyed have had prior experience with recreational cannabis, and 41 percent have consumed it in the past five years. Not surprisingly, the study found that approximately one-third of cannabis consumers indicated an interest in buying products online.

Hill and Knowlton report that environmental, social and governance indicators have never been more important to large investors. The same research found that 57% of medical patients prefer organic cannabis. The survey found 43% of recreational users had the same preference and were willing to pay a premium for the product. Now, the world is watching as Canada stepped into the spotlight in late 2018 as the first G7 country to legalize recreational cannabis nationwide.

Organic Marijuana - Invest in Cannabis